Advocacy | EGFR Lung Cancer Resisters

20 December 2019

Project PRIORITY: Why it matters to the EGFR-positive lung cancer community

Project PRIORITY: Why it matters to the EGFR-positive lung cancer community

laurabbook@gmail.com2019-12-20T23:07:52-08:00

*December 2019* Project PRIORITY (Patient Reported Initiative On Resistance, Incidence, Treatment studY), is a collaboration between LUNGevity Foundation and the EGFR

Project PRIORITY: Why it matters to the EGFR-positive lung cancer communitylaurabbook@gmail.com2019-12-20T23:07:52-08:00

20 December 2019

EGFR Resister Co-Founder Featured on The Today Show for Lung Cancer Awareness Month

EGFR Resister Co-Founder Featured on The Today Show for Lung Cancer Awareness Month

laurabbook@gmail.com2019-12-20T22:25:44-08:00

*November 2019* Jill Feldman, an EGFR Resisters co-founder was interviewed on the Today Show regarding Lung Cancer Awareness Month. Watch

EGFR Resister Co-Founder Featured on The Today Show for Lung Cancer Awareness Monthlaurabbook@gmail.com2019-12-20T22:25:44-08:00

8 November 2019

Learnings from EGFR Resisters’ Project Priority at IASLC 2019

Learnings from EGFR Resisters’ Project Priority at IASLC 2019

laurabbook@gmail.com2019-12-20T22:59:24-08:00

*October 2019* Presented by EGFR Resisters Co-Founders. * Hospitalization - While TKIs are superior to other treatments for EGFR positive lung

Learnings from EGFR Resisters’ Project Priority at IASLC 2019laurabbook@gmail.com2019-12-20T22:59:24-08:00

6 March 2018

How Can Patients Drive Research

How Can Patients Drive Research

cece@reinhardtdesigns.net2018-10-18T16:11:27-07:00

If someone had told me when I was first diagnosed back in 2013 that I would be helping to drive

How Can Patients Drive Researchcece@reinhardtdesigns.net2018-10-18T16:11:27-07:00